Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/97101
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPasricha, S.en
dc.contributor.authorLow, M.en
dc.contributor.authorThompson, J.en
dc.contributor.authorFarrell, A.en
dc.contributor.authorDe-Regil, L.en
dc.date.issued2014en
dc.identifier.citationJournal of Nutrition, 2014; 144(6):906-914en
dc.identifier.issn0022-3166en
dc.identifier.issn1541-6100en
dc.identifier.urihttp://hdl.handle.net/2440/97101-
dc.description.abstractAnimal and human observational studies suggest that iron deficiency impairs physical exercise performance, but findings from randomized trials on the effects of iron are equivocal. Iron deficiency and anemia are especially common in women of reproductive age (WRA). Clear evidence of benefit from iron supplementation would inform clinical and public health guidelines. Therefore, we performed a systematic review and meta-analysis to determine the effect of iron supplementation compared with control on exercise performance in WRA. We searched the Cochrane Central Register of Clinical Trials, MEDLINE, Scopus (comprising Embase and MEDLINE), WHO regional databases, and other sources in July 2013. Randomized controlled trials that measured exercise outcomes in WRA randomized to daily oral iron supplementation vs. control were eligible. Random-effects meta-analysis was used to calculate mean differences (MDs) and standardized MDs (SMDs). Risk of bias was assessed using the Cochrane risk-of-bias tool. Of 6757 titles screened, 24 eligible studies were identified, 22 of which contained extractable data. Only 3 studies were at overall low risk of bias. Iron supplementation improved both maximal exercise performance, demonstrated by an increase in maximal oxygen consumption (VO2 max) [for relative VO2 max, MD: 2.35 mL/(kg ⋅ min); 95% CI: 0.82, 3.88; P = 0.003, 18 studies; for absolute VO2 max, MD: 0.11 L/min; 95% CI: 0.03, 0.20; P = 0.01, 9 studies; for overall VO2 max, SMD: 0.37; 95% CI: 0.11, 0.62; P = 0.005, 20 studies], and submaximal exercise performance, demonstrated by a lower heart rate (MD: -4.05 beats per minute; 95% CI: -7.25, -0.85; P = 0.01, 6 studies) and proportion of VO2 max (MD: -2.68%; 95% CI: -4.94, -0.41; P = 0.02, 6 studies) required to achieve defined workloads. Daily iron supplementation significantly improves maximal and submaximal exercise performance in WRA, providing a rationale to prevent and treat iron deficiency in this group. This trial was registered with PROSPERO (http://www.crd.york.ac.uk/PROSPERO/prospero.asp) as CRD42013005166.en
dc.description.statementofresponsibilitySant-Rayn Pasricha, Michael Low, Jane Thompson, Ann Farrell, and Luz-Maria De-Regilen
dc.language.isoenen
dc.publisherAmerican Society for Nutritionen
dc.rights© 2014 American Society for Nutritionen
dc.subjectHumans; Anemia, Iron-Deficiency; Iron, Dietary; Exercise; Oxygen Consumption; Reproduction; Dietary Supplements; Female; Randomized Controlled Trials as Topic; Observational Study as Topicen
dc.titleIron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysisen
dc.typeJournal articleen
dc.identifier.rmid0030028885en
dc.identifier.doi10.3945/jn.113.189589en
dc.identifier.pubid153186-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS01en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.